(Q37581447)

21 August 2017

1 reference

title

Pharmacotherapy in pediatric obesity: current agents and future directions (English)

1 reference

21 August 2017

0 references

0 references

pediatric obesity

1 reference

Abigail B Wald

1

1 reference

21 August 2017

Naveen K Uli

series ordinal

2

1 reference

21 August 2017

publication date

1 September 2009

1 reference

21 August 2017

number of pages

10

1 reference

Reviews in Endocrine and Metabolic Disorders

inferred from page(s)

published in

1 reference

21 August 2017

volume

10

1 reference

21 August 2017

issue

3

1 reference

21 August 2017

page(s)

205-214

1 reference

https://scigraph.springernature.com/pub.10.1007/s11154-009-9111-y

21 August 2017

exact match

0 references

cites work

Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions

1 reference

https://api.crossref.org/works/10.1007%2FS11154-009-9111-Y

Randomized, double-blind, placebo-controlled trial of orlistat for weight loss in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-009-9111-Y

Effects of sibutramine treatment in obese adolescents: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-009-9111-Y

Treatment of childhood obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-009-9111-Y

Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.

21 January 2018

1 reference

12 December 2020

Prevalence of overweight and obesity in the United States, 1999-2004

1 reference

12 December 2020

Adolescent overweight and future adult coronary heart disease

1 reference

12 December 2020

Short-term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance

1 reference

12 December 2020

Beneficial effects of metformin in normoglycemic morbidly obese adolescents

1 reference

12 December 2020

Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression

1 reference

12 December 2020

Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions

1 reference

12 December 2020

Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial

1 reference

12 December 2020

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

1 reference

12 December 2020

Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin.

1 reference

12 December 2020

Orlistat in the long-term treatment of obesity in primary care settings

1 reference

12 December 2020

Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial

1 reference

12 December 2020

High body mass index for age among US children and adolescents, 2003-2006

1 reference

12 December 2020

Childhood body-mass index and the risk of coronary heart disease in adulthood

1 reference

12 December 2020

Recommendations for treatment of child and adolescent overweight and obesity

1 reference

12 December 2020

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

12 December 2020

1 reference

12 December 2020

Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report

1 reference

12 December 2020

Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion.

1 reference

12 December 2020

Zonisamide for weight loss in obese adults: a randomized controlled trial

1 reference

12 December 2020

Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial

1 reference

12 December 2020

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

12 December 2020

Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy

1 reference

12 December 2020

Clinical review: treatment of pediatric obesity: a systematic review and meta-analysis of randomized trials

1 reference

12 December 2020

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

1 reference

12 December 2020

Interventions for treating obesity in children

1 reference

12 December 2020

Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms

1 reference

12 December 2020

Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial.

1 reference

12 December 2020

Orlistat treatment in obese prepubertal children: a pilot study

1 reference

12 December 2020

Addition of orlistat to conventional treatment in adolescents with severe obesity

1 reference

12 December 2020

Safety and tolerability of topiramate in children

1 reference

12 December 2020

Treatment of obese adolescents with sibutramine: a randomized, double-blind, controlled study

1 reference

12 December 2020

Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach

1 reference

12 December 2020

Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome

1 reference

12 December 2020

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea

1 reference

12 December 2020

The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes

1 reference

12 December 2020

Addition of metformin to a lifestyle modification program in adolescents with insulin resistance

1 reference

12 December 2020

Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder

1 reference

12 December 2020

10.1007/S11154-009-9111-Y

Identifiers

DOI

1 reference

21 August 2017

1 reference